Código QR (código de barras bidimensional)

Characterization of QuantiFERON-TB-Plus Results in Patients with Tuberculosis Infection and Multiple Sclerosis

Background: Disease-modifying drugs (DMDs) for multiple sclerosis (MS) slightly increase the risk of tuberculosis (TB) disease. The QuantiFERON-TB-Plus (QFT-Plus) test is approved for TB infection (TBI) screening. Currently, there are no data available regarding the characterization of QFT-Plus resp...

Fuld beskrivelse

Na minha lista:
Principais autores: Elisa Petruccioli, Luca Prosperini, Serena Ruggieri, Valentina Vanini, Andrea Salmi, Gilda Cuzzi, Simonetta Galgani, Shalom Haggiag, Carla Tortorella, Gabriella Parisi, Alfio D’Agostino, Gina Gualano, Fabrizio Palmieri, Claudio Gasperini, Delia Goletti
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2025-08-01
Serier:Neurology International
Fag:
QFT-Plus
IFN-γ
multiple sclerosis
MS
tuberculosis
Online adgang:https://www.mdpi.com/2035-8377/17/8/119
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker